Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2011-6-2
pubmed:databankReference
pubmed:abstractText
Meningococcal disease incidence is highest in children younger than 2 years of age, yet there is no US-licensed vaccine for this age group. A phase III study evaluated the immunogenicity and safety of an investigational Haemophilus influenzae type b (Hib)-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1098-4275
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
127
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
e1375-85
pubmed:meshHeading
pubmed-meshheading:21624883-Antibodies, Bacterial, pubmed-meshheading:21624883-Antibodies, Viral, pubmed-meshheading:21624883-Bacterial Outer Membrane Proteins, pubmed-meshheading:21624883-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:21624883-Female, pubmed-meshheading:21624883-Follow-Up Studies, pubmed-meshheading:21624883-Haemophilus Vaccines, pubmed-meshheading:21624883-Humans, pubmed-meshheading:21624883-Infant, pubmed-meshheading:21624883-Influenza, Human, pubmed-meshheading:21624883-Male, pubmed-meshheading:21624883-Meningococcal Infections, pubmed-meshheading:21624883-Neisseria meningitidis, pubmed-meshheading:21624883-Orthomyxoviridae, pubmed-meshheading:21624883-Polysaccharides, Bacterial, pubmed-meshheading:21624883-Retrospective Studies, pubmed-meshheading:21624883-Treatment Outcome, pubmed-meshheading:21624883-Vaccines, Conjugate
pubmed:year
2011
pubmed:articleTitle
Immunogenicity and safety of H influenzae type b-N meningitidis C/Y conjugate vaccine in infants.
pubmed:affiliation
University of Louisville, Louisville, Kentucky, USA. k0brya01@louisville.edu
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study